These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3164750)

  • 21. Expression of deoxyadenosine and deoxyguanosine toxicity at different stages of lymphocyte activation.
    Scharenberg JG; Rijkers GT; Toebes EA; Staal GE; Zegers BJ
    Scand J Immunol; 1988 Jul; 28(1):87-93. PubMed ID: 3135585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A canine model of induced purine nucleoside phosphorylase deficiency.
    Osborne WR; Deeg HJ; Slichter SJ
    Clin Exp Immunol; 1986 Oct; 66(1):166-72. PubMed ID: 3026696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts.
    Mann GJ; Fox RM
    J Clin Invest; 1986 Nov; 78(5):1261-9. PubMed ID: 3490493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine.
    Goday A; Simmonds HA; Morris GS; Fairbanks LD
    Clin Exp Immunol; 1984 Apr; 56(1):39-48. PubMed ID: 6424986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of 2'-deoxyguanosine toxicity in mouse T-lymphoma cells with purine nucleoside phosphorylase deficiency and resistance to inhibition of ribonucleotide reductase by dGTP.
    Duan DS; Nagashima T; Hoshino T; Waldman F; Pawlak K; Sadee W
    Biochem J; 1990 Jun; 268(3):725-31. PubMed ID: 2114100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of guanine ribonucleotide accumulation on the metabolism and cell cycle of human lymphoid cells.
    Sidi Y; Hudson JL; Mitchell BS
    Cancer Res; 1985 Oct; 45(10):4940-5. PubMed ID: 2411392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of purine-nucleoside phosphorylase deficiency.
    Albert D; Bluestein HG; Willis RC; Nette K; Seegmiller JE
    Cell Immunol; 1984 Jul; 86(2):501-9. PubMed ID: 6428752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary report on 8-amino-9-(2-thienylmethyl)guanine (PD 119,229), a novel and potent purine nucleoside phosphorylase inhibitor.
    Gilbertsen RB; Scott ME; Dong MK; Kossarek LM; Bennett MK; Schrier DJ; Sircar JC
    Agents Actions; 1987 Aug; 21(3-4):272-4. PubMed ID: 3120507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the enzyme purine nucleoside phosphorylase (PNP) reduces refractoriness to transfused platelets in a dog model.
    Slichter SJ; Deeg HJ; Osborne WR
    Br J Haematol; 1990 Aug; 75(4):591-7. PubMed ID: 2119794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of deoxyguanosine on human lymphocyte function. I. Analysis of the interference with lymphocyte proliferation in vitro.
    Spaapen LJ; Rijkers GT; Staal GE; Rijksen G; Wadman SK; Stoop JW; Zegers BJ
    J Immunol; 1984 May; 132(5):2311-7. PubMed ID: 6425399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histological and immunological evaluation of gnotobiotic C3H/He mice following i.v. administration of 8-aminoguanosine and 2'deoxyguanosine.
    Herrmann MJ; Bealmear PM; Epstein J
    Prog Clin Biol Res; 1985; 181():455-9. PubMed ID: 4023005
    [No Abstract]   [Full Text] [Related]  

  • 32. 8-Aminoguanosine and 8-Aminoguanine Exert Diuretic, Natriuretic, Glucosuric, and Antihypertensive Activity.
    Jackson EK; Gillespie DG; Mi Z
    J Pharmacol Exp Ther; 2016 Dec; 359(3):420-435. PubMed ID: 27679494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of purine nucleosides in human and ovine lymphocytes and rat thymocytes and their influence on mitogenic stimulation.
    Peters GJ; Oosterhof A; Veerkamp JH
    Biochim Biophys Acta; 1983 Jan; 755(1):127-36. PubMed ID: 6402034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consequences of the salvage of purine compounds on the proliferation of rat T-lymphocytes with normal or inhibited purine de novo synthesis.
    Thuillier L; Perignon JL; Houllier AM; Munier A; Cartier P
    Biochim Biophys Acta; 1984 Apr; 798(3):343-9. PubMed ID: 6424727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical and pharmacological properties of CI-972, a novel 9-deazaguanine analog purine nucleoside phosphorylase (PNP) inhibitor.
    Gilbertsen RB; Dong MK; Wilburn DJ; Kossarek LM; Sircar JC; Kostlan CR; Conroy MC
    Adv Exp Med Biol; 1991; 309A():41-4. PubMed ID: 1789255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes.
    Kicska GA; Long L; Hörig H; Fairchild C; Tyler PC; Furneaux RH; Schramm VL; Kaufman HL
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4593-8. PubMed ID: 11287638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective toxicity of purine nucleosides to human leukaemic cells.
    Piga A; Ganeshaguru K; Green ES; Sheridan B; Hoffbrand AV
    Adv Exp Med Biol; 1989; 253B():291-8. PubMed ID: 2514591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo and in vitro pharmacologic activity of the purine nucleoside phosphorylase inhibitor BCX-34: the role of GTP and dGTP.
    Bantia S; Montgomery JA; Johnson HG; Walsh GM
    Immunopharmacology; 1996 Oct; 35(1):53-63. PubMed ID: 8913795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of macrophage-mediated suppression by purine nucleoside phosphorylase substrates.
    Cohen A; Kimchi Z
    J Immunol; 1982 May; 128(5):2253-7. PubMed ID: 6801134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of deoxyguanosine toxicity in T lymphocytes at different stages of maturation.
    Cohen A; Lee JW; Dosch HM; Gelfand EW
    J Immunol; 1980 Oct; 125(4):1578-82. PubMed ID: 6967909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.